7/29/2019 Daily-equity-report by Epic Research 13.02.13

http://slidepdf.com/reader/full/daily-equity-report-by-epic-research-130213 1/4

-=6HEADLINES 

  Indian Market 

  Indian equity markets were up 0.42%

  Nifty up by 24.65 pts and settle at5922.50

  Sensex up by 105.34 pts at 19565.91

  Bank Nifty up by 76.80 pts at 12465.00 

 Global Market 

  European markets were down with FTSEup by 6.12 closed at 6283 ,CAC down by 2.22 closed at 3648 and DAX down by 25.72 closed at 7608. 

  Dow future was down 18.00 closed at

13906.00

WWW.EPICRESEARCH.CO 09752199966 

DAILY EQUITY

NEWSLETTER13

THFEBRUARY 2013

 HEADLINES 

• SAIL Q3 net down 23% on higher 

finance cost, weak Re 

• IT Sector exports seen up 12-14% in

FY2014, says Nasscom

• Expect growth rate of 15-20%, NIMs

sustainable at 5%: REC

• Poor manufacturing, consumption pull

down Dec IIP -0.6%

7/29/2019 Daily-equity-report by Epic Research 13.02.13

http://slidepdf.com/reader/full/daily-equity-report-by-epic-research-130213 2/4

  FII’s and DII’s 

CATEGORY DATE BUY SELL NET

FII 12-Feb-13 2528.32 1924.16 604.16

DII 12-Feb-13 814.97 1227.12 -412.15

  NIFTY DAILY PIVOTS 

IVOT R4 R3 R2 R1 PP S1 S2 S3 S4

IFTY 6034 5993 5952 5937 5911 5896 5870 5829 5788

WWW.EPICRESEARCH.CO 09752199966

 M  ARKET  ANALYSIS : 

 Key benchmark indices edged higher in choppy trade as bargain hunting emerged after a sustained slide

in share prices over the past few trading sessions. BSE Sensex was up 106.14 points or 0.55% to 19,566.71

 CNX Nifty was up 28.35 points or 0.45% to 5,924.20, Among the 30-share Sensex pack, 19 stocks rose while the rest of them fell.

 Oil exploration major ONGC jumped 4.02% on better than expected Q3 results. Jaiprakash Associates

rose 0.14%, with the stock reversing initial losses. The company's net profit fell 64.2% to Rs 110.93crore on 13.33% growth in total income to Rs 3516.83 crore in Q3 December 2012 over Q3 December2011. Power Grid Corporation of India rose 0.4% after net profit jumped 39.52% to Rs 1129.06 crore

on 35.47% growth in total income to Rs 3490.22 crore in Q3 December 2012 over Q3 December 2011.Sail gained 0.27%. The company's net profit fell 23.38% to Rs 484.30 crore on 1.99% decline in total

income to Rs 10670.12 crore in Q3 December 2012 over Q3 December 2011 Pharma stocks rose onrenewed buying. Wockhardt, Lupin and Glenmark Pharmaceuticals gained by 1.51% to 2.83%. Cipla

and Ranbaxy Laboratories fell by 0.68% to 1.19%. Industrial production declined 0.6% in December

2012, data released by the Central Statistics Office (CSO), today, 12 February 2013, showed.

STOCKS TO WATCH

  STERLITE   HDFC   TITAN   INDUSIND BANK 

SCRIPS IN BAN PERIOD 

  WELCORP

  PUNJLYOD

  SUZLON

  IRB

  RENUKA

7/29/2019 Daily-equity-report by Epic Research 13.02.13

http://slidepdf.com/reader/full/daily-equity-report-by-epic-research-130213 3/4

 WWW.EPICRESEARCH.CO 09752199966

.

EXPERT OPINION 

NIFTY

  Nifty looks Bearish

  Strategy: Sell on rise

  Support: 5880

  Resistance: 5970

BANK NIFTY

  Bank Nifty looks Bearish

  Strategy: Sell on rise

  Support: 12400

  Resistance: 12540 

  .0 

 GAINERS   AND LOOSERS 

PREVIOUS  PERFORMANCE 

TYPE SCRIP B/S RESULT

CASH PUNJ LLYOD BSL

TRIGGERED

CASH ONGC SNOT

EXECUTED

FUTURE IDFC S TARGET HIT

FUTUREINDUSIND

BANKB TARGET HIT

UPCOMING  RESULTS 

  BPCL

  IOC

  TATA STEEL

  COAL INDIA

DAILY NIFTY GAINERS

SCRIPS RATE VOL.

(000)

PR.

CLOSE

NET

CHAN

GE

%

CHANG

E

ONGC 320.05 5002.36 308.40 11.65 3.78

Sun

Pharma771.70 1226.29 749.35 22.35 2.98

HCL

Tech678.50 1237.17 659.50 19.00 2.88

Tata

Motors298.55 6616.53 290.90 7.65 2.63

Coal

India345.10 2557.67 338.45 6.65 1.96

DAILY NIFTY LOOSERS

SCRIPS RATE VOL.

(000)

PR.

CLOSE

NET

CHAN

GE

%

CHAN

GE

Jindal

Steel392.20 3422.80 405.75 -3.34 -13.55

IDFC 155.25 6041.48 157.90 -1.68 -2.65

ACC 1239.20 468.85 1258.10 -1.50 -18.90

DLF 267.50 5456.67 271.45 -1.46 -3.95

Infosys 2755.25 555.30 2792.05 -1.32 -36.80

7/29/2019 Daily-equity-report by Epic Research 13.02.13

http://slidepdf.com/reader/full/daily-equity-report-by-epic-research-130213 4/4

 

.

MARKET CALLS 

CASH

SCRIPS ACTION LEVEL 1ST

TARGET 2ND

TARGET STOP LOSS

STERLITE SELL 101.10 100.60 99.85 101.60

HDFC SELL 798.50 796.50 794.50 800.50

FUTURE

SCRIPS ACTION LEVEL 1ST

TARGET 2ND

TARGET STOP LOSS

AUROBINDO

PHARMASELL 179.00 178.00 176.50 180.50

INDUSIND BANK BUY 440.50 442.50 444.50 438.50

 Disclaimer  The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any

responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.

Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on

sources that we consider reliable.

This material is for personal information and based upon it & takes no responsibility

The information given herein should be treated as only factor, while making investment decision. The report does not provide individually

tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and

encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on

the information given in this report, which is in violation of rules and regulations of NSE and BSE.

The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all

estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks

recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views

expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of 

the information is the acceptance of this disclaimer.

All Rights Reserved. Investment in equity & bullion market has its own risks.

We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any

financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to

buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls

or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious

Legal Actions can be taken.